Abstract
Pharmacoeconomics of Selected Essential Medicines for Common Ailments in Sonipat District, Haryana, IndiaAnjali Goyal, Neeraj Gilhotra
Highlights
The Ministry of Health, Ghana in 1983 introduced the Essential Drugs List (EDL) to help to rationalize medicines use in the country (MOH, 1993)
Five hundred medicine outlets comprising of hospitals/health centers/clinics, community pharmacies and chemical shops were surveyed using a validated structured questionnaire
The European Union, recognizing the need for better medicines for children enacted the Paediatric Regulation on 26th January 2007 to improve the health of children in Europe by facilitating the development and availability of medicines for children aged 0 to 17 years (EMA, 2015; Olski et al, 2011)
Summary
The Ministry of Health, Ghana in 1983 introduced the Essential Drugs List (EDL) to help to rationalize medicines use in the country (MOH, 1993). In 1988, the first edition of the Standard Treatment Guidelines (STG), a sequel to the EDL, was published by the Ghana National Drugs Programme (GNDP), an affiliate of the Ministry of Health, Ghana. It is intended to provide quality standardized care at affordable cost, and to ensure that quality essential medicines for adults and children are available at hospitals, clinics, pharmacies and other medicines outlets throughout the country at the right time. The European Union, recognizing the need for better medicines for children enacted the Paediatric Regulation on 26th January 2007 to improve the health of children in Europe by facilitating the development and availability of medicines for children aged 0 to 17 years (EMA, 2015; Olski et al, 2011). The International Pharmaceutical Federation (FIP) and the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) have undertaken to work in tandem with the WHO and other stakeholders to develop and increase the availability of safe and effective child-specific medicines and child-appropriate formulations (FIP, 2008; IFPMA, 2015)
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
